Drugs with modified formulation draw divided reactions

The government and local drug makers remain far apart in their positions over the pricing calculation of formulation-modified drugs over generics.

In a forum organized by the Korea Pharmaceutical Manufacturers Association on July 4, representatives from the domestic pharmaceutical industry said that the government would work out measures to support domestic pharmaceutical companies and minim...